Loading company…
SafeHeal develops medical devices, led by the investigational Colovac, to improve recovery after colorectal surgery.
Founded in 2015 and headquartered in Paris, France, SafeHeal SAS has completed three funding deals. In September 2025 it raised EUR 10 million in Series C funding led by new investor Asabys Partners, as part of a larger EUR 45 million Series C, with returning investors Sofinnova Partners, Gideon Strategic Partners and M&L Healthcare also participating. Colovac, still investigational, aims to protect colorectal anastomoses from fecal matter as an alternative to diverting ostomies, and targets hospitals and surgical clinics in Europe and the United States.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in